Rolls-Royce's artificial intelligence system, known as "Eleanor," offers a peek into how it sees the ultra-wealthy getting around. » Read More
Call it crowd-sourcing for algorithmic trading.
Best Buy reported better-than-expected numbers and the stock spiked. Here are four reasons to get out now, says wealth manager Michael Yoshikami.
Mylan's decision to "gouge" consumers on lifesaving EpiPen devices is corporate "greed on steroids," Ralph Nader tells CNBC.
The high-yield trade this year may soon come to an end, as a possible pickup in growth will cause investors to rotate into other areas.
Jim Cramer fired back Thursday on comments from Mylan CEO Heather Bresch about pricing of the auto-injection device EpiPen.
Pacific Crest reiterates its overweight rating on Palo Alto Networks.
But Dallas Fed President Robert Kaplan refuses to put a timetable on a possible hike.
If you're not succeeding, it may just be that you're not failing enough. Here are 7 lessons from James Altucher, who is a pro at succeeding—and failing.
American banks spent the second quarter crying all the way to the, well, bank.
Shares of enterprise software company Workday jumped after reporting an increase in subscriber revenue.
U.S. equities traded around breakeven a day ahead of a key speech from Federal Reserve Chair Janet Yellen.
The Clinton campaign is promising to pay for Hillary Clinton's flight aboard Air Force One for a campaign appearance last month.
Mylan has reduced the cost of EpiPens for some people — but at the end of the day, its CEO told CNBC she has a business to run.
Dollar Tree and Dollar General reported same-store sales results that fell short of Wall Street's expectations.
Shares of Mylan bounced after the firm announced expansion of existing EpiPen cost-cutting programs.
Mylan announced plans to boost access to its EpiPen Auto-Injector by expanding programs for patients who are facing higher out-of-pocket costs.
Price increases on life-saving EpiPens have parents outraged — but the CEO of the company that makes them said no one's more frustrated than her.
Asana's Dustin Moskovitz gets top-notch ratings from employees for promoting a more balanced culture.
Barry Sternlicht is chairman and chief executive officer of Starwood Capital Group.
Top tech investor Paul Meeks explains one of his rules to investing.
Heather Bresch, Mylan CEO, responds to the controversy surround the company's 400-percent increase for its injectable allergy medicine.
NuTonomy launches the world’s first public trial of self-driving taxis.
NBC News' Tracie Potts reports Donald Trump is going after minority voters claiming Hillary Clinton is a bigot. And Hillary Clinton is expected to fight back against Trump's accusations and calls his shift desperate.
Check out this mashup of some of Suze Orman's best advice and make sure to watch The Susan Orman Show series finale on Saturday, March 28 9p ET.
In the series finale, Oprah Winfrey tells Suze she knew from the very first time she was on her show, that Suze was destined to do something special.
Suze Orman offers a behind the scenes look at her show.